BioHealth News Archive
Doudna Talks Nobel Success and Women in Science
Jennifer Doudna PhD, the UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry with Emmanuelle Charpentier PhD, was the recent guest of…
Read More
BioHealth Crystal Ball on Vimeo
Join Rich Bendis, Pete Briskman and Ann Rutledge as they Discuss Securitization, Covid-19 and Political Analysis related to the BioHealth industry. {iframe}https://vimeo.com/486175068/1f9edf7d87{/iframe}
Read More
Novavax Announces COVID-19 Vaccine Clinical Development Progress | Novavax Inc. – IR Site
GAITHERSBURG, Md., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided…
Read More
Johns Hopkins study shows ‘magic mushrooms’ may be effective in treating major depression – Baltimore Business Journal
Four weeks after receiving monitored doses of psilocybin, researchers reported more than half of the study's 24 participants had achieved remission from their depression.…
Read More
AstraZeneca’s COVID-19 vaccine, up to 90% effective in late-stage trials, is being manufactured in Baltimore – Baltimore Sun
Late-stage trials showed that AstraZeneca’s coronavirus vaccine, which is being manufactured for the United States in Baltimore, was up to 90% effective, the English…
Read More
Maryland Company Poised to Produce Millions of Point-of-Care COVID-19 Tests that Deliver Accurate Results in 15 Minutes · BioBuzz
Rockville, Maryland’s Maxim Biomedical (MaximBio) is on the cusp of bringing 3 million of its new and effective point-of-care COVID-19 tests to the fight…
Read More
Altimmune Announces Submission of Investigational New Drug Application for AdCOVID™ a Single-dose Intranasal COVID-19 Vaccine; On Track to Commence Phase 1 Clinical Study in December Nasdaq:ALT
GAITHERSBURG, Md., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company advancing proprietary intranasal vaccines and peptide therapeutics, today…
Read More
Sisu’s Life Saving Hemafuse Device Introduced in Five Frontier Hospitals of Kenya – APO Group – Africa Newsroom / Press release
BALTIMORE, United States of America, October 29, 2020/APO Group/ -- Sisu Global’s (SisuGlobal.health) flagship medical device is Hemafuse, a surgical autotransfusion device that is…
Read More
Dr. Carol Nacy, CEO of Sequella Incorporated, joins BioTalk to discuss her career, the evolution of their science, and vision for the future.
Listen now via Apple https://apple.co/374aOFI, Google https://bit.ly/3pTGqqj, Spotify https://bit.ly/3nIl7WO, and TuneIn https://bit.ly/3nIl7WO Dr. Nacy co-founded our Sequella in 1997 and has served as our CEO and Chairman of…
Read More
Dr. Carol Nacy, CEO of Sequella Incorporated, joins BioTalk to discuss her career, the evolution of their science, and vision for the future.
Listen now via Apple https://apple.co/374aOFI, Google https://bit.ly/3pTGqqj, Spotify https://bit.ly/3nIl7WO, and TuneIn https://bit.ly/3nIl7WO Dr. Nacy co-founded our Sequella in 1997 and has served as our CEO and Chairman of…
Read More
The risks and rewards of Operation Warp Speed’s approach to vaccines | PBS NewsHour
The race to develop vaccine candidates to prevent COVID-19 represents an unprecedented national and global effort. President Trump and some public health experts say…
Read More
Army teams with Johns Hopkins to advance materials research | Article | The United States Army
ABERDEEN PROVING GROUND, Md. -- The U.S. Army signed a new cooperative agreement with Johns Hopkins University Sept. 30, 2020, to advance materials research using artificial intelligence…
Read More
Alexandria Real Estate Equities, Inc. Achieves the World’s First WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs in New York City
PASADENA, Calif., Nov. 16, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering…
Read More
Funding Opportunities | MSCRF
We offer six programs to accelerate discovery and commercialization of human stem cell-based technologies. Please verify eligibility, read the appropriate RFA below and apply…
Read More